Start for free
Start for free
CG

Chris Gibson

North America, Utah, United States, Salt Lake City

Description

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Direc...

Investor Profile

Chris Gibson has made 11 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (55%)
  • Seed (36%)
  • Series Unknown (9%)

Country Focus

  • United States (64%)
  • Switzerland (9%)
  • United Kingdom (9%)
  • France (9%)
  • Germany (9%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Artificial Intelligence (Ai)
  • Therapeutics
  • Machine Learning
  • Life Science
  • Medical
  • Financial Services
  • Loyalty Programs
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Chris Gibson frequently co-invest with?

Wireframe Ventures
Wireframe Ventures
North America, California, United States, Mill Valley
Co-Investments: 2
Catalio Capital Management
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
EPIC Ventures
EPIC Ventures
North America, Utah, United States, Salt Lake City
Co-Investments: 2
Lifeforce Capital
Lifeforce Capital
North America, California, United States, San Francisco
Co-Investments: 2
Hummingbird Ventures
Hummingbird Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Watermael-boitsfort
Co-Investments: 2
Obvious Ventures
Obvious Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Kindred Capital
Kindred Capital
Europe, England, United Kingdom, London
Co-Investments: 2
Lux Capital
Lux Capital
North America, New York, United States, New York
Co-Investments: 2
Village Global
Village Global
North America, California, United States, Covina
Co-Investments: 2
True Ventures
True Ventures
North America, California, United States, Palo Alto
Co-Investments: 2

Which angels does Chris Gibson often collaborate with?

MS
Michael Secora
North America, Utah, United States, Salt Lake City
Shared Deals: 1
BB
Blake Borgeson
North America, Utah, United States, Salt Lake City
Shared Deals: 1
VC
Viswa Colluru
North America, Colorado, United States, Boulder
Shared Deals: 1
KS
Kulmeet Singh
North America, Texas, United States
Shared Deals: 1
TW
Tom White
North America, Texas, United States, Dallas
Shared Deals: 1
MD
Matt De Silva
North America, California, United States, San Francisco
Shared Deals: 1
KR
Kyle Robertson
North America, Texas, United States, Austin
Shared Deals: 1
BW
Buzz White
North America, Texas, United States
Shared Deals: 1
BM
Blake Marggraff
North America, Texas, United States, Irving
Shared Deals: 1
CK
Chau Khuong
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Chris Gibson?

Dunia Innovation

Berlin, Berlin, Germany

Dunia Innovations is a Breakthrough materials for tomorrow's net zero planet.

Nanotechnology
Series UnknownOct 23, 2024
Amount Raised: $11,500,000
Leash Biosciences

Salt Lake City, Utah, United States

Leash Biosciences engages in machine learning to solve medicinal chemistry.

Health CareMachine LearningMedical
SeedApr 5, 2024
Amount Raised: $9,300,000
Cradle

Zürich, Zurich, Switzerland

Cradle is a biotech company that uses prediction algorithms and AI design recommendations to assist biologists in designing proteins.

Artificial Intelligence (AI)BiotechnologyProduct Research
Series ANov 28, 2023
Amount Raised: $24,000,000
Amenities Health

Dallas, Texas, United States

Amenities Health is the healthcare industry's leading Digital Front Door and patient loyalty platform.

Financial ServicesHealth CareLoyalty Programs
Series ASep 19, 2023
Amount Raised: $6,250,000
Noetik

South San Francisco, California, United States

Noetik is an AI-native biotechnology company.

BiotechnologyLife Science
SeedSep 7, 2023
Amount Raised: $14,000,000
64x Bio

San Francisco, California, United States

64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.

BiopharmaBiotechnologyGeneticsLife SciencePharmaceutical
Series AJan 19, 2022
Amount Raised: $55,000,000
Known Medicine

Salt Lake City, Utah, United States

Known Medicine combines patient-specific 3D cell culture and AI to translate drugs to clinical success

Artificial Intelligence (AI)BiotechnologyHealth CareLife ScienceMedical
SeedAug 25, 2021
Amount Raised: $7,200,000
Enveda Biosciences

Boulder, Colorado, United States

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

BiotechnologyPharmaceuticalTherapeutics
Series AJun 22, 2021
Amount Raised: $51,000,000
Enveda Biosciences

Boulder, Colorado, United States

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

BiotechnologyPharmaceuticalTherapeutics
SeedAug 11, 2020
Amount Raised: $4,900,000
Inato

Paris, Ile-de-France, France

Inato is a platform designed for clinical trials that can unlock research site potential.

Artificial Intelligence (AI)Clinical TrialsHealth CareMachine LearningPharmaceutical
Series AFeb 4, 2020
Amount Raised: $14,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator